Portfolio company · 01
Cannivest
Cultivation & Extraction
GACP-aligned cultivation and extraction operator producing pharmaceutical-grade cannabis flower and API for the European medical channel.
Read company profileYunit Capital · Green Growth Fund
Portugal's medical cannabis opportunity, institutionalised.
A CMVM-regulated private equity fund managed by Yunit Capital Partners, offering qualified investors curated exposure to Portugal's most promising licensed cannabis operators.
The manager
Backed by Yunit Group
Yunit Capital Partners is an independent private equity firm regulated by the CMVM, part of Yunit — a group with deep advisory heritage in foreign direct investment, corporate finance and M&A, and close ties across Portugal's business landscape.
€40M+
investment supported by Yunit Group
2
offices — Lisbon & Porto
3
operating companies in the fund
Why now
Europe's medical cannabis market is maturing. Portugal is where it's produced.
€36.2B
European medical cannabis market by 2033
CAGR ~22% from €6.06B in 2024
32,558 kg
Portuguese exports in 2024
up 172% year-on-year
#2
global exporter of medical cannabis
second only to Canada (INCB)
200,000+
patients with prescriptions in Europe
and rising with EU harmonisation
01
Regulatory tailwind
Germany's rescheduling and the harmonisation of medical frameworks across the EU have unlocked a structurally growing prescription market — imports into Germany nearly tripled in 2025 to ~201 tonnes.
02
Portugal as the EU hub
INFARMED oversight aligned to GACP/GMP standards, world-class agronomy and EU logistics make Portugal the second-largest producer in Europe and a preferred source for Germany, the UK and Spain.
03
Pharma-grade demand
The European medical channel needs standardised, GACP/GMP output — the scarce input that reimburses at pharmaceutical, not commodity, pricing.
04
Institutional access
A CMVM-regulated fund vehicle gives qualified investors curated exposure to a fragmented sector — with governance, disclosure and reporting held to institutional standards.
Sources: European Parliament · INCB · Prohibition Partners · INFARMED · Statista
The portfolio
Three companies. One vertically integrated platform.
The Green Growth Fund holds a curated stake across cultivation, extraction and distribution — a full value chain governed by a single institutional lens.
Portfolio company · 02
Plantomax
AgTech & Cultivation
Precision-agriculture and controlled-environment expertise driving yield, consistency and unit-economics across the fund's cultivation footprint.
Read company profilePortfolio company · 03
Qanali
Distribution & Brand
Commercial platform for finished medical cannabis products — packaging, licensing and distribution into pharmacies and EU medical channels.
Read company profileDetails available to qualified investors
The investor journey
From interest to allocation, in a guided sequence.
01
Discover
Explore the fund thesis and public materials.
02
Register
Submit interest — we review every request personally.
03
NDA & KYC
Sign digitally, complete qualification checks.
04
Subscribe
Access documentation and formalise your commitment.
05
Report
Quarterly reporting, IR contact, portfolio updates.
Get in touch
Register your interest
Reserved for qualified investors. All submissions are reviewed by our investor relations team.